Wenbin Chen

2.8k citations
57 papers · 1.5k indexed · h-index 20
Topics
Liver Disease Diagnosis and Treatment (10 papers)Thyroid Disorders and Treatments (9 papers)Cancer-related molecular mechanisms research (6 papers)

In The Last Decade

Wenbin Chen

53 papers receiving 1.5k citations

Peers

Wenbin Chen
Comparison fields: 5 of 110
  • Molecular Biology 798
  • Epidemiology 402
  • Endocrinology, Diabetes and Metabolism 278
  • Cancer Research 241
  • Physiology 164
Replace Michelle L. Boland with:
Michelle L. Boland United States
Guojun Zhao China
Zhigang Wang China
Pierre‐Damien Denechaud France
Sehwan Jang Puerto Rico
Stephen L. Pinkosky United States
Robert A. Egnatchik United States
Raquel Fucho Spain
Xiwen Xiong China
Yaxi Chen China
Wenbin Chen relative to Michelle L. Boland United States Michelle L. Boland's profile →
Citations per field
00.5×1.5×
Michelle L. Boland · 1×
Citations per year

Countries citing papers authored by Wenbin Chen

Since Specialization
Citations

This map shows the geographic impact of Wenbin Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenbin Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenbin Chen more than expected).

Fields of papers citing papers by Wenbin Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenbin Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenbin Chen. The network helps show where Wenbin Chen may publish in the future.

Co-authorship network of co-authors of Wenbin Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Wenbin Chen. A scholar is included among the top collaborators of Wenbin Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenbin Chen. Wenbin Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 2
3 7
4 8
5 23
6 5
7 8
8 10
9 2
10 6
11 4
12 12
13 18
14 26
15 49
16 61
17 20
18 12
19 31
20 211

About Wenbin Chen

Wenbin Chen is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research and Epidemiology, having authored 57 papers that have together received 1.5k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (10 papers), Thyroid Disorders and Treatments (9 papers) and Cancer-related molecular mechanisms research (6 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (278 citations), Cancer Research (241 citations) and Molecular Biology (798 citations). Wenbin Chen has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Ling Gao, Jiajun Zhao, Shanshan Shao, Tao Bo, Chao Xu, Chunxiao Yu, Guowang Xu, Yongfeng Song, Akio Asai and Shunji Chi. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026